Drug Type Small molecule drug |
Synonyms JNJ 41443532 |
Target |
Action antagonists |
Mechanism CCR2 antagonists(C-C chemokine receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H25F3N4O3S |
InChIKeyCFKBNYUHQSQBSX-CYWCHRQTSA-N |
CAS Registry1228650-83-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | - | 01 Dec 2010 |
Phase 2 | 89 | Placebo | kipewxjqfk(ihvgrvqztt) = oaaubtojel tkovbmhyyj (ijpasyocrh, 7.23) View more | - | 11 Dec 2013 |